​

Silexion Therapeutics Ownership | Who Owns Silexion Therapeutics?

OverviewFinancialsChart

Silexion Therapeutics Ownership Summary

Silexion Therapeutics is owned by 1.13% institutional investors, 8.05% insiders, and 90.82% retail investors.

SLXN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSilexion Therapeutics1.13%8.05%90.82%
SectorHealthcare Stocks 35.75%11.89%52.37%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026716.67%36,47999.18%1329.09%2-33.33%2-
Dec 31, 2025650.00%18,315260.18%-290.67%3---100.00%
Sep 30, 20254100.00%5,085-86.04%-255.84%350.00%1-
Jun 30, 20252-36,414---2---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 26, 2026Shirvan Mitchell CSO and CDOSell$31.03K

SLXN Ownership FAQ

Who Owns Silexion Therapeutics?

Silexion Therapeutics shareholders are primarily institutional investors at 1.13%, followed by 8.05% insiders and 90.82% retail investors. The average institutional ownership in Silexion Therapeutics's industry, Biotech Stocks , is 36.05%, which Silexion Therapeutics falls below.

Does Blackrock own Silexion Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Silexion Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools